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Abstract
The protein Rukhôl was expressed in the fusion vector pGEX-4T-l and the 
recombinant organism grown in Luria broth and minimal media. Ruk is expressed 
early in rat development, in a variety of tissues. Ruk is of interest because of its 
interaction with proteins in the signal transduction pathway. It is known to inhibit a 
PI3-kinase pathway which involves Akt/PKB. The mode of action of this protein is of 
interest because it may lead to new anti-cancer drugs. The protein was purified using 
affinity chromatography. Thrombin protease was used to cleave the GST tag from the 
target protein and affinity chromatography used to remove the GST tag from the 
solution containing the target protein. Concentration of the protein has been achieved 
through the use of column chromatography, the freeze drying of samples, and by 
ammonium sulphate precipitation. Through the course of the work, the protocol for 
the purification of GST-Rukh61 has been optimised, as has the protocol for the 
cleavage of the GST tag and the concentration of the protein.
The protein GST-Mb has also been expressed in small quantities. Mb is of interest 
because it is found in mice in neuronal tissue only and it is only found during the later 
stages of development. Mb responds to nerve growth factors thus its mode of action, 
investigated through structural studies, is of interest. It has been transformed into a 
different Escherichia coli (& coli) strain, from that in which it was obtained, to 
facilitate expression. The Mb can also be cleaved from the GST using thrombin 
protease. Work on the optimisation of the protocols for Mb is ongoing.
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1. Introduction
The overall objective of this project is to optimise the expression and the purification 
of two unrelated proteins. This would then lead to the preparation of samples for 
NMR analysis and structural studies.
The proteins of interest are Rukh61 and Mb. Rukh61 is a shortened version of Ruk, it 
is more amenable to NMR studies through being smaller whilst being able to give an 
indication of the 3D structure of Ruk. Structure determmation by NMR is currently 
limited to proteins of <300 (~30kDa) amino acids"^ "^  because the number of resonances 
in larger proteins gives an overcrowded, overlapped spectrum which is very difficult 
to assign. Ruk is able to inactivate phosphatidylinosito 1-3-kinase (PI3-kinase) signal 
transduction pathways,^^ which in turn leads to the inactivation of Akt/PKB and the 
mechanisms that are dependent on it, mechanisms such as the activation of glycogen 
synthesis, and the regulation of cell survival.^^
Mb is found in neuronal tissue of chicks, humans, mice and rats, and is only found in 
the later stages of development.^^ The amino acid sequence shows a repeat unit with a 
region in-between the repeating units which sequence analysis indicates may be a 
loop structure. Further sequence analysis of this loop region has led to the conclusion 
that it may be more than one small loop.^^
The pGEX GST^’^  expression system is used to obtain high level expression and rapid 
purification of GST tagged proteins. Genes encoding Mb and Rukh61 have been 
cloned into the vector pGEX-4T-l to produce the plasmid with antibiotic resistance so
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that only the desired protein grows. Ampicillin (AMP) resistance is conferred by the 
pGEX vector and chloramphenicol (CAP) resistance is conferred by the E. coli. strain 
BL21(DE3)pLysS.
A vector map of the pGEX-4T-l vector is shown in Figure 1.
The site labelled thrombin is the recognition site and cleavage is seen to occur 
between Arg and Gly.
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I Leu vâi S o  Arg | Gly sër | Pro Glu Phe Pro Gly Arg Leu Glu Arg Pro His Arg Asp Stop 
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Sal 1EcoR 1 Not 1 Stop codone
BamH 1 Xho 1Sma 1
NiaBal 1
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4969 bpBspw 1
AlwN 1
lad pBR322Nar I EcoR V /
B ssH ll M l u  1
BstE 11
Figure 1 : Vector map of pGEX-4T-l
This diagram shows the genetic map for the pGEX vector with thee sites of intCTest, i.e. the 
thrombin site and the positions of restricticm sites that are unique within this vector.
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1.2 Introduction to Ruk
The protein Rukh61 is a shortened version of the protein Ruk and is the heart variant. 
Ruk is involved in the phosphoinositide 3-kinase (PI3-K) and serine-threonine kinase 
(Akt/PKB) signal transduction pathway. It deactivates Akt/PKB by inhibiting PI3-K. 
Akt/PKB was discovered by two groups independently who named it differently/''^ to 
avoid confusion the term Akt/PKB shall be employed throughout this thesis.
Ruk Structure
There are three principle forms of Ruk mRNA, resulting in three variations of the 
protein: long, medium and short.^^ Figure 2 shows the schematic structure and 
possible splicing forms of Ruk. The protein under investigation in this work is the 
shortened form of Ruk, known as Rukh61. This is the short protein shown in Figure 2 
with a coiled-coil domain only.
11
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SCHEMATIC STRUCTURE AND POSSIBLE SPLICING FORMSOF Ruk
B PROLINE-RICHREGION COILED-COILDOMAIN
SH3 I  SH3 g  SH3 |  | g
Long
Medium
PEST
REGION
PROLINE-RICH
REGION COILED-COILDOMAIN
I SH3 I I I
PES 
REGION
COILED-COIL
DOMAIN
Short
Figure 2: The Structure of Ruk
There are three principle forms of Ruk proteins. These are shown above and are labelled as l«ig, medium 
and short, referring to their relative lengths. Rukhôl is the Wiort protein observed in the diagram. This 
diagram shows the regions that are found in the differently spliced forms of the protein. SH3 domains are 
found in many signalling molecules and bind selectively to proline-rich sequences. PEST regions are 
regions rich in proline, serine and threonine.
The carboxy terminal domain of the family of Ruk proteins is conserved throughout 
the heart, lung and skin variants of the rat protein.This  is in contrast to the N- 
terminal domain containing SH3 domains and a proline rich domain which vary 
amongst the tissues. The PEST region is a pro line, serine and threonine rich region 
which is usually present in proteins with a high metabolic turnover/^ SH3 domains 
contain 55-70 residues and are present in a large number of signalling molecules.^ The 
structures of SH3 domains that have been solved are similar to each other.^ They are 
known to selectively bind to proline-rich sequences, such as that present in Rukhbl. 
SH3 domains mediate protein-protein interactions akin to those required in some 
signal transduction pathways.^ Proteins can have multiple SH3 domains, for example, 
the long form of Ruk as shown in Figure 2, allowing the potential to form a cluster of
12
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several distinct ligands. Serine or threonine phosphorylation adjacent to the pro line 
rich ligand can influence SH3 domain interactions.^ The prolines have two roles in the 
interaction between an SH3 domain in an adapter protein, such as GRB2, and a 
pro line-rich domain in another. The pro line-rich sequence assumes an extended 
conformation that allows extensive contacts with the SH3 domain.^^ A subset of these 
proline sequences is thought to fit into binding pockets on the surface of the SH3 
domain.^ SH2 domains bind specific phosphotyrosyl residues on activated receptors.’ 
Serine phosphorylation of an SH3 recognition site results in the uncoupling of 
signalling proteins.’
C-terminal domain of Ruk
It has been proposed, on the basis of structure prediction, that the C-terminal domain 
of Ruk has a coiled-coil structure.^^ This type of structure is formed from two 
amphipathic a-helices wrapped around each other. An amphipathic a-helix is one in 
which the hydrophilic side chains are on one side of the helix and the hydrophobic 
side chains are on the opposite. Within a coiled-coil structure the helices wrap around 
each other with the hydrophobic residues projecting from one helix interdigitating into 
the gaps between the hydrophobic side chains of the other helix along the contact 
surface. The amino acid sequence of each amphipathic helix contains a characteristic 
7-residue “heptad” repeat, in which the hydrophobic residues are predominately at 
positions a and d. A study of coiled-coils has shown that it takes at least three heptads 
or six helical turns to cause a molecule to adopt a coiled-coil conformation in aqueous 
media.*
13
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level of intetph&se
Figure 3: Illustration of a coiled-coil.
A coiled-coil occurs when two amphipathic 
helices wrap around each other and the 
hydophobic residues at positions a and d in the 
diagram interdigitate into the gaps in the other 
helix alœig the contact surface. Figure 4: An example of a coiled-coil. GCN4 leucine zipper. ‘
Figure 3 shows an illustration of the amphipathic nature of helices. ** The coiled-coil 
motif is quite tolerant to sequence variation as is shown by the variety that appear in 
nature.^ The coiled-coil structure is also found in the Gal4 dimer and the leucine- 
zipper dimer family. Leucine zippers are a widely observed structural motif which 
promotes homo- and hetero-dimerisation in some DNA-binding proteins.* 
Dimerization occurs through the formation of a short parallel coiled-coil of a-helices. 
The zipper is characterised by a heptad repeat of leucine residues at position d. 
Another heptad repeat of hydrophobic residues occurs at position a. These residue 
pack against each other in the coiled-coil structure .In  many natural and artificial 
leucine zippers asparagine, in position a, enforces a parallel orientation of strands. An 
example of a leucine zipper is GCN4. This is shown in Figure 4 above.**
Other examples from nature include the coiled-coil domain in kinesin which is
14
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structurally important for co-ordinating the activities of kinesin heads during 
processive movement.*^ Tropomyosins are a family of actin binding proteins found in 
eucaryotic cells. Tropomyosin is a coiled-coil protein along its length apart from the 
ends, it binds to actin in such a vyay as to align the ends.*  ^Multimerin is a 1228 amino 
acid, soluble protein that is found in platelets and endothelium blood vessels, the 
central portion of its sequence shows a coiled-coil structure. The role of this domain 
has not yet been determined, but it has been assumed to be a site for interchain 
associations.*"*
In the case of the C-terminal of Ruk the proposed coiled-coil structure is underlined in 
the sequence of Rukh61 shown. This was obtained from Buchman^^ and shows the 
coiled-coil to be between residues 53-110. A consensus of eight types of structure 
prediction was carried out*  ^using Network Protein Sequence Analysis at IBCP. This 
gave a coil structure for residues 1-11, 15-34 and 40-41; a sheet structure for residues 
12-14 and a helical structure for residues 35-39 and 42-110. This helical structure 
could make up the coiled-coil. Analysis using the method developed by Lupas et al}^ 
for the prediction of coiled-coils from protein sequences gave a probability of > 0.99 
of a coiled-coil between residues 53 and 105, which is again close to the residues 
shown. The use of PHD (Profile fed neural network systems from HeiDlberg) gave 
rise to similar results with a prediction of helices for residues 51-107.*^
Coiled-coil sequences in nature have many variations with a leucine molecule at 
position d being, in general, retained. The coiled-coil domain of Rukhôl shows 
approximately 40% similarity with a range of leucine zipper domains, including the 
coiled region of GCN4, with the leucine zipper investigated by Jelesarov** and with a
15
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natural bZIP protein investigated by Moitra et al 19
Rukhôl contains 110 amino acids, the sequence being:
MAAASSGPAS LSSVASSPMS SSLGTAGQRA SSPSLFSAEG KAKTESAVSS 
OAAIEELKMO VRELRTIIET MKDOOKREIK OLLSELDEEK KIRLRLOMEV 
NDIKKALOSK
Rukhôl has a molecular weight of 11.89Ô kDa, to this is added a GST tag of 2Ô kDa 
to enable the easy purification of the protein, giving a combined molecular weight, 
before cleavage, of 38 kDa. Rukhôl has been cloned into the vector pGEX-4Tl by 
Buchman^^ and was expressed in Escherichia coli (E. coli) strain BL21(DE3)pLysS.
The computer programme ‘Protean’^ ** was used to determine the statistics of Rukhôl 
from its amino acid sequence. Table 1 shows results of the analysis carried out.*^
Molecular Weight 1189Ô.00 Da
I microgram = 84.0Ô2 pMoles
Molar Extinction coefficient 0
1 A(280)= *
Isoelectric point 9.355
Charge at pH 7 2.928
Table 1 : The analytical data of Rukhôl predicted from the amino acid sequence. 
*Rukh61 has no amino acids which show at an absorbance of280nm.
16
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PI3-K
PI3-K is a heterodiiner made up of 110 kDa and 85 kDa subunits .^These  subunits 
are referred to as pi 10 and p85, the pi 10 subunit containing a catalytic domain which 
confers lipid kinase activity and a binding site for wortmannin, an inhibitor of 
PI3-K?* The p85 subunit contains two proline rich motifs which are responsible for 
binding to src homology 3 (SH3) domains/^ these are protein-protein interaction 
domains. It also contains two src homology 2 (SH2) domains.^* The p85 subunit 
shows no kinase activity.^* The p85 subunit can be further subdivided into a p85a and 
ap85p domain.
Role o f Ruk and Interaction with PI3-K
It has been shown by Buchman^^ that Ruk RNA is expressed in the first fifteen stages 
of new-born rat development, with the level of expression dropping as development 
continues. It has also been shown that in different tissues, for example skin, muscle 
and heart, different versions of Ruk RNA are expressed. Buchman has also obtained 
evidence that Ruk can, in vitro, interact with proteins involved in the signal 
transduction pathway.^^ This was found through an investigation of the SH3 domains 
of Ruk and then binding to proteins with SH3 and SH2 domains, especially the N- 
terminal SH3 domain of GRB2. GRB2 contains an SH2 domain which binds to 
phosphotyrosine residues and two SH3 domains.^^ Experiments in vitro have shown 
that the SH3 domains of Ruk bind well to p85a which is a regulatory subunit of 
PI3-K.^*’^  ^This complex between the subunit and Ruk also exists in vivo, as has been 
shown through immunoprécipitation experiments by Buchman.^^ This also showed 
that the p85a subunit and not the p85(3 subunit complexes with Ruk. Further 
experiments showed that the PI3-K activity is inhibited by the presence of Ruk.^^
17
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Continued experiments by Buchman using sensory neurons (these are dependent on 
neurone growth factor which is inhibited by Ruk) with the plasmid to produce Ruk, 
have shown that it only needs the SH3 and/or the proline rich domain of the protein to 
inhibit survival of the neurons. Th^ means that the coiled-coil domain is not used to 
form the complex with p85a. Experiments on these neurons also showed^^ that the 
effect of Ruk is reversible by activating downstream members of the pathway, that is, 
the injection of active Akt/PKB or PI3-K will allow the survival of neurons.
Akt/PKB
Akt/PKB is a serine-threonine kinase, which contains a pleckstrin homology (PH) 
domain at the N-terminal, residues 1-106.^  ^ This domain regulates the activation of 
Akt/PKB through the binding of the D3-phosphorylated phosphoinositides that are 
produced by PI3-K. "^* The phosphorylation of Akt/PKB influences its activation and 
the PH domain may also influence the activation by promoting dimerization and the 
formation of Akt/PKB protein complexes.^^ It is known that Akt/PKB activation is 
part of a PI3-K dependent signalling pathway, because when treated with two 
unrelated PI3-K inhibitors, such as wortmannin and LY294002, the Akt/PKB is not 
activated. The data collected by Burgering and Coffer, "^* using an epitope-tagged 
version of Akt/PKB, led them to the conclusion that PI3-K activation is essential for 
Akt/PKB activation to occur. Akt/PKB has been found to show increased activity 
after treatment with platelet-derived growth factor (PDGF), epidermal growth factor 
(EGF), insulin and basic fibroplast growth factor (bFGF). "^* The intracellular 
signalling pathways, through which growth factors promote survival of neurons in the 
central nervous system, are not well characterised. Pathways which include PI3-K are 
important for the survival of several cell lines,^^ however the modes of operation are
18
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unclear. Two targets of PI3-K are Akt/PKB and p70 S6 -kinase (p70^^^) which 
contribute to the insulin-like growth factor 1 (IGF-1) mediated survival of cerebellar 
neurons.^^ It has been established that IGF-1 and insulin activate PI3-K in cerebellar 
neurons, this occurs as they induce binding of PI3-K to the receptor-associated protein 
IRS-1 (insulin receptor substrate 1).^  ^ IRS-1 mediates the activation of PI3-K and 
IGF-1 and insulin increase the activity of PI3-K.^^ Insulm and the IGF-1 also activate
p7 0 S6 k^  but the phosphorylation of p70^^^ is blocked by the PI3-K inhibitor
wortmannin, which suggests that p7 0 S6 k activation is dependent upon PI3 -K.^ **’^ ^
Figure 5 shows the pathway of activation of Akt/PKB. It starts at the insulin receptors 
and goes through the activation of the pi 10 subunit of PI3-K by the p85 subunit or by 
activated RasGTP.^^ RasGTP is activated by SOS and Shc-GRB2.^^ Then the 
subsequent phosphorylation of Akt/PKB occurs.^* LY294002 is an inhibitor of PI3-K 
and is shown as not reacting in the activation pathway. The reaction of 
phosphatidylinositol (4,5)-diphosphate [PtdIns(4 ,5 )P2] with PI3-K leads to the 
production of PtdIns(3 ,4 ,5 )P3. The reaction of PtdIns(3 ,4 ,5 )P3 with PLP (phospholipid 
phosphatase), leads to the production of PtdIns(3 ,4 )P2, as is shovm in the diagram. 
Both of these products bind to the PH domain of Akt/PKB and stimulate its activation 
through the phosphorylation of Thr308 and Ser473.^* The activation of Akt/PKB 
involves a change in conformation.^*’^**
The diagram shows that the activation of Akt/PKB is Ras-dependent,^^’^  ^ suggesting 
that it may be a member of a signalling pathway. The data obtained by T. F. Franke et 
al suggests that Akt/PKB ftmctions in a pathway that is Ras-dependent but MAP 
kinase independent, such a pathway involving MEKK and INK was recently
19
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described^^ so there is a precedent. The other pathway shown in Figure 5 involves Ras 
interaction with serine/threonine kinases of the Raf family. When Raf has been 
activated by activated RasGTP it phosphorylates, and thus activates, MEK. This 
pathway is interrupted by PD90859 as shown.^*
Insulin Receptors
I
pfls
Pt<Jlns-4,5-P2_^ ^
LY294002 4 p 1lO
P I3K
PLP — _
. b B T
i
PM Ins 3,4 P 2 PMlns 3,4,5 P3
PD90ÔS9
Raf
i
MEtC
1
AftatyPKB
pattiway
ERK/N4APK
pattiway
Figure 5 : The activation of Akt/PKB.
This shows the path of activation of Akt/PKB from the stimulation by the insulin receptors of the p85 
subunit. The pi 10 subunit of P13-K is activated by interaction with either the p85 subunit or with 
activated RasGTP.^^ RasGTP is activated by SOS and Shc-GRB2. ruk can also interact and is capable 
of disrupting the activation process. LY294002 is an inhibitor of P13-K and is shown as not reacting in 
the activation pathway. Ptdlns(4,5)P2 reacts with PI3-K to produce PtdIns(3,4,5)P3. This intCTacts with 
PLP to give PtdIns(3,4)P2. Both of these bind to the PH domain of Akt/PKB and stimulate activation 
through the phosphorylation of Thr308 and Ser473. The activation of Akt/PKB involves a change in 
conformation.^*’^  The other pathway shown involves Ras interaction with serine/threonine kinases of 
the Raf family. Once Raf has been activated it phosphorylates and activates MEK. This pathway is 
interrupted by PD90859 as diown.^'
Burgering and Coffer^ "* also undertook a study of the mechanism of Akt/PKB 
activation to investigate whether Akt/PKB is regulated by phosphorylation, this 
Akt/PKB was induced by PDGF and inhibited by treatment with wortmannin.
20
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Analysis of the Akt/PKB showed that phosphorylation was mainly on Ser473. The 
phosphorylation appears to be essential for Akt/PKB kinase activity as treatment of 
active Akt/PKB with phosphatase removed the ability of Akt/PKB to be 
phosphorylated. One response to the activation of Akt/PKB is the activation of
pYOSbk This provides evidence that Akt/PKB is an element of a growth factor 
induced signal transduction pathway and implies that the PI3-K pathway is sensitive 
to oncogenic conversion, and thus may be important in the development of human 
cancer?"*'^ * PI3-K and Akt/PKB have been implicated in neuronal differentiation and 
survival/^ PI3-K has a role in the mediation of NGF-induced neurogenesis and in the 
survival of PC 12 cells. In these cells PI3-K activity is controlled through the Shc- 
binding site on Trk, which is not required for NGF-mediated cell survival.^^ It appears 
that PI3-K is a member of a pathway that collaborates with other pathways in the 
regulation process. Akt/PKB can be activated by phosphatidylinosito 1-3,4- 
biphosphate, which is a secondary messenger generated by PI3-K activity.^ ** Inactive 
Akt/PKB is able to block KCl- and insulin-mediated survival, thus indicating that 
Akt/PKB is a key component of cell survival of cerebellar neurons.^**
There are three main stages in the promotion of activation of Akt/PKB by PI3-K 
derived messengers. First translocation of the kinase to the membrane occurs, 
followed by the attachment of the kinase to the membrane by way of the PH domain 
binding to phospholipid and finally phosphorylation occurs. This is shown in Figure 
6, which is a model for the activation of Akt/PKB by PI3-K dependent mechanisms.^**
21
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Figure 6: The Akt/PKB Pathway
This diagram shows the pathway of Akt/PKB activation starting from inactive Akt/PKB in the bottom 
left comer. First translocation of the kinase to the membrane occurs, followed by its attachment to the 
membrane by way of the PH domain binding to phospholipid [Ptdlns(3,4,5)P3] and then 
phosphorylation occurs at Thr308 and at Ser473 producing active Akt/PKB. This is shown in mwe 
detail in Figure 5. Activated Akt/PKB is involved in many activities as shown in the diagram. 
Included in these activities is the phosphorylation of glycogen synthase kinase-3, GLUT-4 
translocatiwi, cell cycle regulation and, through other pathways, protein synthesis.
Figure 6 shows that following growth-factor receptor simulation,^** the pi 10 subunit 
of PI3-K is activated by interaction with the p85 subunit and activated RasGTP. The 
activation of PI3-K produces both phosphatidylinositol (3,4,5)-triphosphate 
[PtdIns(3,4,5)P3] and PtdIns(3,4)P2.^* “  The PH domain of Akt/PKB binds to these 
phosphoinositides, recruiting Akt/PKB to the plasma membrane and stimulating 
kinase activity this domain has been shown to be essential for Akt/PKB activation.^* 
The full activation of Akt/PKB requires phosphorylation of Thr308 and Ser473, 
utilising two kinases (PDKl and PDK2) which are dependent for activation on 
PtdIns(3,4,5)P3.^** The activation of Akt/PKB involves a change in conformation.^*’^**
Akt/PKB is responsible for the phosphorylation of glycogen synthase kinase-3, which 
not only results in its inactivation, but also in the activation of glycogen synthesis.
22
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This is important as PKBa is amplified and overexpressed in many ovarian 
neoplasms. Akt/PKB has been found to stimulate glucose uptake and GLUT4 
translocation. Further experiments by Dudek et af^  showed that the promotion of 
survival by insulin requires Akt/PKB. Thus, another function of Akt/PKB is to 
mediate the effects of IGF-1 on neuronal survival, this may promote the survival of a 
range of growth factors that activate PI3-K. Activated PI3-K and Akt/PKB have been 
shown to protect epithelial cells from apoptosis caused by the detachment of adherent 
cells from their extracellular matrix. "^  ^ Pathways other than PI3-K can lead to 
Akt/PKB activation. DiCi6PtdIns-3,4-P2 works even when wortmaimin has blocked 
PI3-K.^^
Another type of signalling pathways are those which contain receptor tyrosine kinases 
(RTK’s). These signalling pathways have a wide spectrum of functions including 
regulation of cell proliferation and differentiation, promotion of cell survival and 
adjustments in cell metabolism.^ PI3-K is an effector of Ras,^  ^Ras proteins are critical 
components of signalling pathways leading firom cell surface receptors to control of 
cellular proliferation.^^ They are also involved in morphology and differentiation. Ras 
is able to regulate PI3-K which is important in Ras control of cellular morphology and 
DNA synthesis.^^
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1.3 Introduction to Mb
Mb is a neurospecifîc protein which is non-hydrophobic and thus is soluble/'^^ It has 
a molecular weight of 9.29kDa^^ which is increased to 35kDa by the addition of a 
Glutathione S-Transferase (GST) tag. The DNA for the protein has been isolated from 
chicken neural screening, the protein itself is expressed in a recombinant form. Mb 
contains 83 amino acids and has been described by Buchman^^ as having two 
repeating units with a ‘novel’ loop in-between. The repeat units are underlined in the 
sequence and the homologies shown. A structure prediction, obtained from 
Buchman^^ and shown in the Appendix 1, shows predictions for the chick, human, 
mouse and rat varieties. The one of interest is the chicken form as that is the strain 
under investigation in this work.
The structure prediction in Appendix 1 is a Momany prediction^^ and shows a 
probable helix structure for residues 7-18 and 70-80. It also predicts a lop structure at 
residues 30-35 and 50-53. The probability of a loop structure is conserved in the 
mouse and rat form, but in the human form whilst a helix is predicted in that region, 
there is also a high probability of a loop being present.
A consensus of eight types of structure prediction was carried out^  ^ using Network 
Protein Sequence Analysis at ÏBCP. This gave a coil structure in residues 3-10, 17-20, 
30-36, 39-46, 50-53, 60-79 and 82-83. Of these residues 30-36 and 50-53 correspond 
to those seen as loops in the Momany prediction and residues 39-46 are in a region 
where the Momany prediction is unsure of the structure. The remaining residues are 
within the repeat units. Another structure prediction using the method developed by
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Rost and Sanders^^ also agrees with the Momany prediction, indicating a loop 
structure for residues 31-34, 40-44 and 49-52.
The amino acid sequence is
MLDTISSOYD SFIYWRMPIP RLELAELEGL GLGQGSLYAP HSKLPEAAQE 
PGCAEEDSLL PFSSFNFWRA PIASISSFDF DLI
The homology between the N-terminal and the C-terminal regions of Mb can be seen 
here:
N t e r m i n a l  D T IS  S  Q YDS F I  YtJRHP IP  RLELAELEGL 
I : ; :  I I : I I I 1 ; s ; ï
C t e r m i n a l  D S L L -P F SS F N F U R A P IA S IS SF D F D L I
Mb is found in the neuronal tissue of mice, but not in the spleen, lung, heart, liver or 
kidney. It was found by Buchman^^ to be regulated by the development of the mice. 
There is a sharp increase in the expression of Mb in the mouse hindbrain, this occurs 
during the later stages of development. The Mb responds to nerve growth factors in 
rat cell line PC 12 and again shows expression at a late stage of development.
Mb is expressed in the vector pGEX-4Tl, which has a thrombin cleavage site and was 
obtained from Buchman in the E. coli strain X90. It has been expressed in this strain 
and also in the E. coli strain BL21(DE3)pLysS.
The computer programme ‘Protean’^  ^has been used to determine the statistics of Mb 
from its amino acid sequence. Table 2 shows the results of the analysis carried out.^^
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Molecular Weight 9285.9 Da
1 microgram = 107.690 pMoles
Molar Extinction coefficient 15340 ± 5%
1 A(280) = 0.61 mg/ml
Isoelectric point 4.008
Charge at pH 7 - 7.938
Table 2: The analytical data of Mb, obtained from the amino acid sequence
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2. Methods
Qiagen Maxi Plasmid Purification Protocol
The bacterial pellet from an overnight eighteen hour culture was resuspended in 10 ml 
of solution PI, resuspension buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 
100 pg/ml RnaseA, 4°C). 10 ml of solution P2, lysis buffer (200 mM NaOH, 
1% SDS), was added, and the solution mixed gently four to six times and incubated at 
room temperature for five minutes. 10 ml of chilled P3, neutralisation buffer (3.0 M 
potassium acetate, pH 5.5,4°C), solution was added, the solution mixed gently four to 
six times and incubated on ice for twenty minutes. The solution was then centrifuged 
at 20,000 g for thirty minutes at 4°C and the supernatant promptly removed. The 
supernatant was then centrifuged for a further fifteen minutes under the same 
conditions.
A Qiagen tip-500 was equilibrated by applying 10 ml of buffer QBT, equilibration 
buffer (450 mM NaCl, 50 mM MOPS, pH 7.0, 15% isopropanol, 0.15% Triton 
X-100), and the column allowed to empty under gravity. The supernatant resulting 
from step five was applied to the tip, and allowed to enter the column by gravity flow. 
The Qiagen tip-500 was then washed twice with 30 ml of buffer QC, wash buffer 
(1.0 M NaCl, 50 mM MOPS, pH 7.0, 15% isopropanol). The DNA was eluted by the 
addition of 15 ml of buffer QF, elution buffer (1.25 M NaCl, 50 mM Tris-HCl, 
pH 8.5, 15% isopropanol). The DNA was then precipitated by the addition of 0.7 
volumes of room temperature isopropanol. The solution was immediately centrifuged 
at 15,000 g for thirty minutes at 4^C, and the supernatant removed. The DNA pellet
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was washed with 5 ml of 70% ethanol, air dried for five minutes, and redissolved in 
100 pi of TE (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) and RNase.
Transformation of DNA
In a laboratory environment plasmid DNA can be introduced into bacteria by the 
artificial process of transformation. It is in such bacteria that the DNA can grow and 
divide. Using sterile equipment, 20 pi of a suspension of competent cells of the type 
BL21(DE3)pLysS were transferred to a sterile microfiige tube on ice. 0.5 pi of DNA 
was added and gently mixed. A blank and a test plasmid were also prepared. The 
microfiige tubes were then stored on ice for 30 minutes. Subsequently the tubes were 
heated at 42°C for exactly 42 seconds to heat shock the cells, and then placed on ice 
to allow the cells to chill for 2 minutes. 80 pi of SOC medium (SOC medium is 
obtained from Sigma, it is a complex buffered medium commonly used for growing 
high-efficiency competent DNA) was added to each tube and the tubes incubated at 
37°C for 45 minutes to allow the bacteria to recover and to express the antibiotic 
resistance marker that is encoded by the plasmid. 50 pi of the cells were transferred to 
a Luria agar plate containing 100 pg/ml ampicillin (AMP), and these were spread over 
the surface using a bent sterile rod. The plates were left at room temperature until the 
liquid had been absorbed and then inverted and incubated at 37°C overnight.
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Cultivation of protein
10 ml of Luria Broth (LB) medium containing 100 pg/ml AMP and 34 pg/ml 
chloramphenicol (CAP) was inoculated with a single colony from an agar plate 
containing the E. coli BL21(DE3)pLysS with GST-Rukh6L This was incubated 
overnight at 37°C, 200 rpm, then added to 500 ml LB similarly treated in a 2 L flask 
and incubated at 37°C, 200 rpm until the optical density (OD) Aeoo was approximately 
0.6. Over-expression was induced by the addition of isopropyl-1-thiol-p-D- 
galactoside (IPTG) to a final concentration of 1 mM and incubation was continued for 
180 minutes. The cells were harvested by centrifugation for 20 minutes at 8000 g, 4°C 
and the pellets frozen for storage.
Minimal Media
Minimal media is used to express proteins enriched with and for use in NMR 
studies. The media used in this work was M9 media which contains autoclaved 
deionized water (800 ml), 5X salts (200 ml), 1 M MgS0 4  (2 ml), 1 M CaCE (0.1 ml) 
and filter sterilised 20% glucose (20 ml).
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Preparation of Cell Extract of Rukh61
The pellets were resuspended in a solution composed of ice cold PBS (phosphate 
buffer solution), DNase (20 pg/ml), and MgCE (10 mM). This was left on ice for 15 
minutes while the DNA was degraded and the viscosity of the sample reduced. 
Dithiothreitol (DTT) (5 mM) was added to break disulphide bonds in the GST tag and 
to maximise GST binding to the glutathione beads. The resulting solution was 
sonicated on ice for 30 seconds with a 2 minute rest. This was repeated three times. 
The cell debris was removed through centrifugation for 15 minutes at 15000 g, 4°C 
and the supernatant retained.
Preparation of Cell Extracts of Mb
Sonication was used to break open the cells and to ensure that all the protein was 
recovered. The pellets were resuspended in ice cold STE (Sodium chloride, Tris, 
ETDA) buffer (40 mM Tris(hydroxymethyl)aminomethane, 150 mM NaCl, 1 mM 
EDTA, pH 8) with ice cold lysozyme (10 pg/ml), DNase (20 pg/ml), and MgCE 
(10 mM). This was left on ice for 15 minutes and the procedure for Rukh61 followed 
fi:om then on.
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Preparation Of Glutathione Sepharose-4B Beads
The beads were washed twice with 10 bed volumes of phosphate buffer solution, PBS, 
(140 mM NaCl, 2.7 mM KCl, 10 mM NazHP0 4 , 1.8 mM KH2PO4, pH 7.4) to 
equilibrate them. On completion of the purification of the target proteins the beads are 
cleaned using a high pH buffer (0.1 M Tris-HCl, 0.5 M NaCl, pH 8.5) and a low pH 
buffer (0.1 M NaAc, 0.5 M NaCl, pH 4.5). This was repeated twice before storing in 
PBS.
Purification Using Glutathione Sepharose-4B Beads
The supernatant from the clarification of the sonication solution was filtered onto the 
beads, and incubated for 30 minutes at room temperature with gentle agitation. The 
solution was centrifuged at 500 g for 5 minutes to sediment the beads and the 
supernatant removed. The beads were washed with 5-10 volumes of PBS containing 
2 mM PMSF (phenylmethanesulphonyl fluoride), to remove any contaminants and 
again centrifuged at 500 g for 5 minutes and the supernatant removed. This was 
repeated until the beads were clear of impurities. Once the beads appeared to be clear 
of impurities they were washed with a cleavage buffer (2.5 mM CaCE, 150 mM NaCl, 
50 mM Tris, pH 8.0) which removed any non-specifically bound impurities that the 
PBS had not. The GST fusion proteins bound to the beads and were eluted using 1 
volume of elution buffer (75 mM Hepes, 150 mM NaCl, 5 mM DTT, 10 mM reduced 
glutathione, pH 7.4). This was left to incubate for 10 minutes at room temperature 
with gentle agitation. The solution was centrifiiged again at 500 g for 5 minutes to
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sediment the beads and the supernatant retained. This was repeated until the beads 
were clear of proteins.
Thrombin Cleavage To Remove GST Tag
Thrombin cleavage is possible due to a 6 amino acid recognition site (Leu Val Pro 
Arg Gly Ser) cloned into the protein. Thrombin protease cuts between Arg and Gly.
One unit of thrombin protease is defined as the amount of thrombin required to cleave 
> 90% of 100 pg of a test GST-fiision protein in PBS at 22®C in 16 hours.
Determination of Protein Concentration - Dye-Binding Procedure
The Bradford assay technique was used. Bradford Reagent^^ was produced by 
dissolving 100 mg of Coomassie Brilliant Blue G-250 in 50 ml of 95% ethanol mixed 
with 100 ml of 85% w/v phosphoric acid, diluted with water to one litre and filtered. 
A calibration curve was produced using stocks of BSA (bovine serum albumin) of 
known concentration. This reagent was mixed 3 ml : 60 pi sample and the absorbance 
at 595 nm measured against, a blank. This technique utilises the fact that the binding 
of Coomassie Brilliant Blue G-250 to protein causes a shift in the absorption maxima 
of the dye from 465 nm to 595 nm.
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3. Techniques
Affinity Chromatography - Glutathione Sepharose Purification
Affinity chromatography is an adsorption chromatographic method in which the 
protein to be purified is specifically, and reversibly, adsorbed by a ligand immobilised 
on an insoluble support matrix. Purification can be in the order of several thousand 
fold and sample recovery is high. Affinity chromatography also has a concentrating 
effect.
Sepharose is a bead-formed agarose gel which is commonly used as a matrix. It has an 
open-pore structure with an exclusion limit in gel filtration of 20 x 10  ^ molecular 
weight, this makes the interior of the matrix available for ligand attachment and 
allows good binding capacity relative to other matrices. Sepharose 4B exhibits low 
non-specific adsorption, which leads to good separation. The ligand used in affinity 
chromatography has to exhibit specific, reversible binding affinity for the substance to 
be purified and it has to be attached to the matrix without destroying the binding 
capacity. A spacer arm can be added between the ligand and the matrix to facilitate 
binding of substances otherwise affected by steric interference.
The purification of recombinant fusion proteins that contain at the carboxy terminus a 
GST tag is achieved using an immobilised glutathione chelating group. Glutathione 
Sepharose 4B, available from Pharmacia Biotech, has glutathione attached via a 10 
carbon spacer arm to the oxirane group of activated Sepharose 4B. The structure of
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glutathione is complimentary to the GST binding site, hence purification of the GST 
fusion proteins is possible via affinity chromatography. Cleavage of the target protein 
is via a specific protease cleavage site. In the case of proteins in the pGEX-4Tl vector 
the GST can be cleaved fi*om the target protein using thrombin.
Removal of Salts and Exchange of Buffer by Diaib^ sis
The protein solution is placed in tubing of semi-permeable membrane and the dialysis 
tubing is placed in the required buffer. Small molecules can pass fireely across the 
membrane whilst large molecules are retained. The membrane is made of cellulose 
acetate with pores of between 1-20 nm in diameter, the pore size determining the 
minimum molecular weight of molecules retained by the membrane. The pore size is 
chosen so that molecules that are larger than the pores cannot pass through the 
membrane, thus salt exchange is possible but protein of a molecular weight higher 
than the cut-off wiU not pass through the membrane.
Pre-treatment of dialysis tubing ensures a uniform pore size and removal of any heavy 
metal contaminants. When benzolylated dialysis tubing with a cut-off of 5 kDa is to 
be used, the tubing is prepared by soaking in water for three hours with fresh water 
every hour. Dialysis tubing with a higher cut-off point is treated differently, as it 
needs to have heavy metal contaminants removed. This type of tubing is boiled for 10 
minutes in a large volume of 2% (w/v) sodium bicarbonate, 1 mM EDTA, pH 8.0 
solution. The tubing is then rinsed in distilled water and boiled for 10 minutes in 1 
mM EDTA, pH 8.0 solution. The tubing is cooled and stored in 20% ethanol at 4°C, it
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is rinsed with distilled water before use. The tubing is handled with gloves following 
the first stage of the treatment.
Equilibrium between the solution inside the tubing and the solution outside of the 
tubing is usually reached after 3 hours with efficient stirring using 15 kDa cut-off 
membranes.^^ As the molecular weight cut-off decreases, the time to equilibrium 
increases. Thus for tubing with 5 kDa a significantly longer time is required before 
equilibrium is reached than for tubing with a 15 kDa cut-off.
Gel Permeation Chromatography
This technique can be used to exchange the buffer of a solution and to separate 
different sizes of proteins. The volume of solution that can be exchanged into a 
different buffer by this technique is dependent upon the size of column used. The 
maximum volume should not be more than 30% of the column volume, if it is more 
then resolution between the protein and the salt fi*om the previous buffer will not 
occur. This method results in dilution of the sample.
One method of protein concentration is to exchange the buffer solution to ammonium 
bicarbonate. This is a volatile solution and can be removed through freeze drying. 
There are two methods of exchange: the first is dialysis and the second is gel 
permeation chromatography. The gel permeation chromatography is faster and uses 
less buffer to carry out. The recovery of the protein is also higher.
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Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Polyacrylamide gels are formed by the copolymerization of acrylamide monomers 
with a cross-linking agent to form a 3D lattice. The best and commonest cross-linker 
for PAGE is N, N’-methylene bisacrylamide. Polymerisation is initiated with 
ammonium persulphate and N, N, N% N ’-tetramethylethylenediamine. The 
concentration of acrylamide in the gel determines the effective separation range of the 
SDS-PAGE, for example, a 10% gel separates proteins in the molecular weight range 
of 15-200 kDa. Some small polypeptides and peptides (< 5 kDa) cannot be completely 
separated as the small molecules form SDS-protein complexes of the same dimension 
and charge leading to them migrating together during SDS-PAGE.
SDS is an anionic denaturing detergent and a solubilizing agent. It is used with (5- 
mercaptoethanol to dissociate proteins in a sample into their polypeptide subunits. 
Each subunit binds the same amount of SDS per unit weight (1.4 g SDS per 1 g 
protein) and takes on the same net negative charge. Thus, all peptides in the sample 
will have the same charge density and separation will occur based on molecular 
weight. When electrophoresis begins the proteins migrate through the gel, separating 
according to size. This type of gel is used to determine the sizes of the proteins 
present in a sample and the purity.
The gels are stained by Silver or Coomassie Brilliant Blue. Silver staining is a more 
sensitive technique and is used for gels run on the Phast^^ system, where typically, 
samples contain only 5 ng of protein and both the separation and staining procedures 
are automated. The gels for this system are pre-poured by the manufacturer.
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Coomassie Brilliant Blue staining of gels prepared in the laboratory involves leaving 
the gels with gentle agitation in a large excess of Coomassie Brilliant Blue for 4 
hours. The excess dye is removed by draining off the solution and rinsing the gel with 
an excess of a solution of 45% MeOH, 10% acetic acid.
Silver staining of a gel not run on the Phast™ system is carried out as follows. All of 
the rinses are with gentle agitation. The gel is first rinsed for 15 minutes in a solution 
of 50% MeOH, 10% acetic acid. The next rinse is 15 minutes in 5% MeOH, 7% acetic 
acid. These two rinses prefix the gel, final fixing is achieved using 10% 
gluteraldehyde solution for 15 minutes. The gel is then rinsed in distilled water for 2 
hours with fresh water after 1 hour. The gel is next rinsed in 5 pg/ml DTT for 15 
minutes and then in 0.1% silver nitrate for 15 minutes. The gel is then ready to be 
developed using 3% sodium carbonate, 0.02% formaldehyde solution. The gel is 
darkened until it is the required colour and the reaction stopped with 5% acetic acid.
For a gel run on the Phast^^ system the silver staining technique is similar but the 
system is automated and thus the time for development of the gel is pre-set. The first 
step is a wash in 50% EtOH, 10% acetic acid. The next wash is in 10% EtOH, 5% 
acetic acid. Following this is a sensitising step using 8.3% gluteraldehyde in water. 
The gel is then washed in deionized water. Following this the gel is treated with 
0.25% (w/v) silver nitrate and then developed using 0.015% formaldehyde in 2.5% 
sodium carbonate. The development stage is stopped using 5% acetic acid in water. 
As a final stage the gel is treated with preserving solution of 10% acetic acid, 10% 
glycerol.
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4. Results And Discussion
4.1 Expression And Purification Of Rukh61
Expression of Rukh61
Rukh61 was obtained in the form of DNA which was then transformed into the E. coli 
strain BL21(DE3)pLysS using the protocol described earlier.
GST-fused Rukhbl has been over-expressed in quantities up to 25 mg/L of pure 
protein. The pLysS cells in which Rukh61 has been expressed releases lysozyme, 
which breaks the cells open on freeze-thawing. Sonication can be used for the same 
effect and was used to ensure that all the protein was recovered. It was discovered 
during the course of this work that proteolytic cleavage was occurring. To prevent the 
Rukhbl degrading through this proteolysis phenylmethanesulphonyl fluoride (PMSF), 
from a 0.2 M stock in ethanol, was added to all of the solutions except those in which 
thrombin cleavage occurs. When PMSF is only added to the lysis buffer some 
degradation of GST-Rukh61 still occurs during the purification process. PMSF is used 
to inactivate serine proteases. Cysteine proteases can be inactivated through the use of 
N-ethyl maleimide (NEM) which is added at lysis only. This was included in the 
protocol because a band at 20 kDa appeared on gels after lysis that was not present 
before. The addition of NEM solved this problem.
Purification of GST-Rukh61
At the start of this project sarkosyl (1.5%) was added to the lysis solution to
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encourage the solubilization of the protein. It was found that this was not required as 
GST-Rukh61 is expressed in a soluble form. During this time Triton X-100 (1%) was 
added to encourage binding to the glutathione Sepharose beads, as sarkosyl 
solubilized GST does not bind well to agarose beads without the use of a detergent.
After lysis the solution was clarified by centrifugation. The clarified protein solution 
was applied to the glutathione Sepharose 4B beads and the impurities removed by 
washing with PBS containing 2 mM PMSF. The Bradford Assay was used on the 
wash fi’actions to determine if all of the impurities had been removed. Table 3 shows a 
typical set of Bradford readings for the cleaning of the beads and Figure 7 shows a gel 
of the ft-actions.
mg/ml of protein
Pass (20ml) 1.243
Wash 1 (40ml) 0.842
Wash 2 (40ml) 0.373
Wash 3 (40ml) 0.156
Wash 4 (40ml) 0.094
Wash 5 (40ml) 0.065
Wash 6 (40ml) 0.010
3* kDa- 
26kDa-
Table 3: The Bradford readings fi*om a typical purification of Rukh61.
Figure 7: Gel of the stages of washing of the 
glutathione beads.
This is a 12% acrylamide gel that was stained using 
Coomassie Blue. The markers in lane 1 are at 94 kDa, 
67 kDa, 43 kDa, 30 kDa, 20.1 kDa and 14.4 kDa 
(largest at the top). Lane 2 is the pass of supernatant 
from the clarification of the beads. Lanes 3-8 are 
washes 2-6.
1 2  3 4 5 6 7 8
Using the markers in lane 1 of Figure 7 as a reference, it can be seen that there is a 
band at 38 kDa and at 26 kDa in lanes 2-5. As lane 2 is the supernatant and lanes 3-8
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are washes of the beads, this implies that GST~Rukh61 and GST have both been 
expressed but have not bound completely to the beads. This problem can be solved by 
the addition of Triton X-100 to the supernatant before it is applied to the beads. This 
can lead in turn to the creation of another problem, the concentration of Triton X-100 
in the supernatant must not be so high as to cause unfolding of the protein. If Triton 
X-100 is not added to the solution from sonication then the target protein does not 
bind as well to the beads. If it is found that not all of the protein has bound to the 
beads then the solution is reloaded and the remaining protein purified. It was found 
that Triton X-100 at 0.1% enables binding to the glutathione beads to be increased. It 
was also found that if the beads are used repeatedly then the binding capacity 
deteriorates.
Figures 8 and 9 show the elution of GST-Rukh61 from the glutathione Sepharose 
beads. These gels show that in Rukh61 there is a pseudo thrombin site, this is GKA 
and the thrombin is able to cleave between the K and A. When the thrombin protease 
was allowed to work on the protein for longer than 20 hours then cleavage at this 
pseudo site occurred. Cleavage at this site gave two smaller proteins rather than 
Rukh61. Table 4 shows basic data that was obtained about these smaller proteins 
using the computer program ‘Protean’.
Molecular weight 3.816 kDa 8.097 kDa
pi 9.007 9.080
Charge at pH 7.0 0.911 1.926
Table 4: Proteins produced by cleavage at pseudo thrombin site.
The data in this table was obtained using ‘Protean’, an analysis program, and is based on the amino 
acid sequence of Rukh61 cleaved at the pseudo thrombin site.
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Figure 8: The elution of GST-Rukh61 from 
glutathione Sepharose beads when PMSF is 
not used.
Lane 1 contains the markers at 94 kDa, 63 kDa, 
43 kDa, 30 kDa, 20 kDa and 14 kDa (largest at the top). 
Lane 2 is empty. Lanes 3-8 show elution fractions.
V /
1 2  3 4 5 6 7 8
Figure 8 shows the elution fractions obtained from glutathione Sepharose beads when 
PMSF is not used in the purification procedure. Lanes 3-5 show the fused protein at 
38 kDa, GST at 26 kDa and a band that appears to be cleaved Rukh61 at 11 kDa (faint 
line). Lane 6 shows the fused protein at 38 kDa and GST at 26 kDa. Lanes 7, 8 show 
only GST. This gel shows that proteolytic cleavage occurs when PMSF was not used 
in the elution and washing buffers. The bands at 26 kDa appear to be double bands, 
this implies that cleavage was occurring at more than one site. The proteases normally 
present should not be cleaving at the thrombin protease cleavage site but the GST- 
Rukh61 is cleaving in such a way as to suggest that this is occurring.
*MkDa—  
67 kDa 
43 kDa----
30 kDa----
20.1 kDa 
14.4 kDi
Figure 9: The elution of GST-Rukh61 from 
glutathione Sepharose beads when PMSF has 
been included in the buffers.
Lane 1 contains the markers at 94 kDa, 63 kDa, 
43 kDa, 30 kDa, 20 kDa and 14 kDa (largest at the top). 
Lanes 2-6 show elution fractions.
Figure 9 shows the elution fractions obtained from glutathione Sepharose beads when
41
c. Stolton
PMSF is used in the purification procedure. In contrast to Figure 8, there are only 
bands at 38 kDa (fused protein) and at 26 kDa. This implies that the use of PMSF 
prevents protease cleavage occurring. The presence of a 26 kDa band in the elution 
fractions of GST-Rukh61 implies that the fused protein is cleaving whilst expression 
is occurring. The band at 26 kDa is not likely to be an E. coli protein.
The elution buffer used to remove the GST-fiised protein from the glutathione beads 
contained reduced glutathione. This had to be removed from the protein solution prior 
to thrombin cleavage as it interferes with the reaction. The removal can be carried out 
through dialysis against PBS, however as the glutathione was removed, the protein 
fell out of solution. Thus, at a concentration of only 1 mg/ml GST-Rukh61 became 
insoluble. Altering the pH to 6.5 improved the solubility, as did reducing the salt 
content. Eluted GST-fused Rukh61 can be concentrated using dialysis, however, 
concentration using centrifugation caused cleavage of the protein to occur through 
shearing against the membrane.
Thrombin Cleavage
Time course experiments at different temperatures have shown that the temperature 
for fast cleavage of the GST tag from Rukh61 is 37°C with a gentle agitation of 
75 rpm but at this temperature cleavage also occurs immediately at the pseudo site. 
Time studies of the cleavage have also been carried out and these show that cleavage 
overnight (20 hours) at 22°C (room temperature) is enough to cut all of the protein 
present if sufficient thrombin protease is present in the solution. The use of 2 units of 
thrombin protease per mg of protein is sufficient, and does not lead to excessive
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cleavage at the pseudo thrombin site.
Prior to thrombin cleavage the GST-fiised Rukh61 was originally dialysed into PBS 
but method development has lead to the use of a buffer known as the cleavage buffer 
(see Section 2 for details). The cleavage was carried out using 2 units of thrombin per 
mg of GST-Rukh61. Thrombin cleavage yields 5 mg of cleaved protein from 18 mg 
of uncleaved protein produced by 1 L of broth.
The cleaved protein solution is re-applied to the glutathione beads to remove the GST 
from the solution. This is because the GST binds to the beads but the Rukh61 does 
not.
Thrombin Cleavage on Glutathione Sepharose Beads
An alternative method of thrombin protease cleavage which eliminates glutathione 
totally from the protein solution is to cleave the GST-Rukh61 whilst it is attached to 
the Glutathione Sepharose 4B beads. In this case the elution step of the purification 
protocol was not carried out, instead 1 volume of cleavage buffer was applied to the 
beads after the washes and thrombin protease added to a final concentration of 
2 units/mg of fused protein.
The amount of fused protein present can be estimated from prior knowledge of yields. 
Determination of the yield of GST-Rukh61 prior to cleavage is carried out by the 
removal of 0.5 ml of the beads and eluting it with elution buffer. The total yield was 
then calculated from the yield of that fraction.
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Figure 10: Gel of the 
cleavage of GST-Rukh61. 
This is a 15% SDS-PAGE 
acrylamide gel that has been 
silver stained. Lanes 1 and 13 
contain low molecular weight 
(LMW) markers, as shown.
Lanes 2-10 show stages of 
cleavage. Lanes 11-12 show how 
purity can vary with different 
wash buffers.
I 2 3 4 5 6 7 8 9 U) II 12 13
To analyse the cleavage of the GST-Rukh61 samples were taken after V2 hour, 1 hour, 
2 hours, 3 hours, 5 hours and 20 hours. These are shown in Figure 10, lanes 2-7. After 
6 hours of cleavage the beads were split into two batches: one was left overnight until 
it had been reacting for 20 hours and the other batch was eluted immediately. Lane 8 
is the elution of the beads after 20 hours of cleavage, showing GST and Rukh61 only. 
Lane 9 shows a sample taken after 6 hours and lane 10 shows the elution after 6 
hours, with fused Rukh61, at 38 kDa still present. This gel also shows cleavage 
occurring at the pseudo thrombin site, which can be seen by the presence of a double 
band at 11 kDa. Lane 11 is an example of cleavage of a sample cleaned with cleavage 
buffer and lane 12 is an example of cleavage when a wash with cleavage buffer has 
not been carried out.
Concentration of the protein 
Ultrafiltration
The most commonly used method of concentration is the use of ultrafiltration in an 
Amicon concentrator where pressure and a stirring bar are used to force the solvent 
through a membrane. Initially protein is lost to the membrane using this method
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however, once the membrane has been saturated with the required protein, no more is 
lost. The concentration of Rukh61 was carried out using the common method of 
ultrafiltration in an Amicon concentrator. This method can have a high percentage of 
loss for small amounts of proteins. For example, a sample containing 11 mg of protein 
was concentrated this way and 70% of the protein was lost, it did not pass through the 
membrane and soaking the membrane to remove loose protein did not increase the 
yield. This problem may be solvable through saturating the membrane with another 
protein or through changing the membrane type. If the protein is unfolded then it may 
be sticking to the container in which case the above solutions would have no effect.
Centrifugation
Centrifugation methods can be used as the membranes can be treated with glycerol to 
prevent the proteins sticking, unfortunately centrifugation methods cannot be used for 
the concentration of GST-Rukh61 because the protein appears to be sheared using this 
method.
Figure 11: Gel of the products from 
centrifugation of GST-Rukh61.
Lane 1 contains a sample from the waste 
solvent side of the membrane. Lanes 2 and 4 
31 kDa contain LMW markers. Lane 3 contains the
20.4kDa/ original sample of GST-Rukh61. (Lanes 5
19.7 kDa and 6 contain samples of GST eluted from a
16.9 kDa column after cleavage of the Rukh61)
14.4 kDa 
6.1 kDa 
3.5 kDa
n  2-^ 3 4  5-45^
The gel in Figure 11 shows the products of centrifugation in Lane 1, these protein 
fragments have passed through the membrane. The sample seen in lane 3 is the 
original sample prior to centrifugation, it can be seen that this sample contains GST as 
well as GST-Rukh61. Lanes 2 and 4 contain LMW markers, the numbers shown on
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the side of the gel refer to these markers. Lanes 5 and 6 contain samples of GST 
eluted from a column after cleavage of the Rukh61 and are not connected with 
centrifugation. As can be seen there is protein passing through the membrane and 
small proteins are visible which are not seen in the original sample. This implies that 
the protein is being sheared by the centrifugation concentration procedure.
Dialvsis
Dialysis against a solution of 20 K PEG is one method of concentrating protein or the 
use of dry PEG for a quicker concentration. These both lead to a loss of GST-Rukh61 
and of Rukh61 and to the protein falling out of solution when it reaches 1 mg/ml. 
Dialysis into ammonium bicarbonate with a view to freeze drying leads to a 20% loss 
of the protein when there is initially 8 mg of protein.
Gel permeation chromatographv
The concentration of protein can be achieved through the exchange of protein into a 
suitable solution such as ammonium bicarbonate and freeze drying to remove the 
volatile solvent. Unfortunately concentration through the use of a G25 column and 
freeze-drying can lead to unfolding of proteins. Further investigations into this 
technique can be carried out once it is certain that the protein is folded to start with.
The gel in Figure 12 shows the fractions from a G25 Sephadex column after freeze- 
drying. Lane 1 contains LMW markers. Lanes 2-6 contain fractions 8-12 of the 5 ml 
fractions collected. Lane 7 shows a sample containing Rukh61 and GST.
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31 kDa 
21».4kD a S  l9.7kDa: 16.9k Da
l4 4 k D a -----
6.1 kDa 
3.5 kDa
Figure 12: Fractions from G25 
Sephadex column.
Silver stained 15% acrylamide gel of the 
fractions from a G25 Sephadex column after 
freeze-drying. Lane 1 contains LMW 
markers. Lanes 2-6 contain fractions 8-12 of 
the 5 ml fractims collected. Lane 7 shows a 
sample containing Rukh61 and GST.
The gel in Figure 12 was overloaded to show up the impurities which are from non­
specific proteins binding to the glutathione beads. These impurities can be removed 
from the beads by washing them with the cleavage buffer prior to the cleavage step. 
The purity of the samples obtained by washing with cleavage buffer is shown in 
Figure 13.
Figure 13: Cleavage of Rukh61-GST.
Lane 1 contains LMW markers as does lane 4. Lane 
2 shows the supernatant and lane 3 shows the beads 
after 20 hours of cleavage. Lane 5 shows the 
centrifuged supernatant, containing cleaved 
Rukh61.31 kD a21» 4 kD a /l9 7 k D a —
16 9kD a
l4 .4kD a
6 I kD a 
3.5 kD a
In Figure 13, lane 1 contains LMW markers as does lane 4. Lane 2 shows the 
supernatant and lane 3 shows the beads after 20 hours of cleavage. Lane 5 shows the 
centrifuged supernatant, containing cleaved Rukh61. These samples are a lot purer 
than those where PBS alone has been used, as in Figure 14. This is the method that is 
now used.
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It has been found that the cleavage buffer removes the majority of these non- 
specifically bound impurities from the beads, leading to a more pure product after 
thrombin cleavage, prior to application to the G25 Sephadex column.
Ammonium sulphate precipitation
Another method of concentration of a protein is ammonium sulphate precipitation 
where the protein is precipitated by the addition of ammonium sulphate and 
resuspended in a smaller volume of buffer. The addition of ammonium sulphate to 
80% is required to precipitate the protein. This can then be pelleted by centrifugation 
at 20,000 g for 30 minutes. This method of concentration is presently being looked 
into, however preliminary experiments indicate that this method of concentration 
leads to a high percentage yield with few losses.
Table 5 shows examples of the different concentration techniques and the losses that 
occur on their use. The techniques that retain the highest percentage of Rukh61 are, 
unfortunately, those that are most damaging to the protein.
Concentration Technique % Rukh61 remaining
G25 column 97
Dialysis against ammonium bicarbonate 78
Dialysis against PEG 32
Amicon concentrator 30
Table 5: Different concentration techniques that were tested and the amounts of 
Rukh61 remaining at the end of the concentration procedure.
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Growth of Rukh61 under differing conditions
GST-Rukh61 has been over-expressed in Luria broth, Terrific broth and in M9 media 
before purification on the glutathione Sepharose 4B beads. The yields for these 
different media are shown in Tables 6-8 below. Rukh61 was expressed in Terrific 
broth because it has previously lead to higher yields, in this case it did not. It was 
expressed in M9 (minimal) media as this is the method used to produce labelled 
protein for NMR studies.
Tables 6-8 show the results of these experiments in different media. It can be seen 
from the data that the yield of GST-Rukh61 is similar regardless o f the media in 
which it is produced. GST-RuMi61 was expressed in Luria media on six occasions to 
provide the data in the table below. It was expressed once in M9 media and in Terrific 
Broth with the intention to repeat the work when other problems had been solved and 
the method of expression had been further optimised.
Luria Broth Yield (mg/L) % Total Proteiu Error (mg)
Total Protein 110 mg ±20
Pure GST-Rukh61 25 mg 22.7 ± 4
Cleaved Rukh61 7 mg 6.4 ±0.5
Table 6: The expression of GST-Rukh61 in Luria broth.
This shows the percentage of total protein obtained in the form of Rukh61. The experiment was 
repeated six times to calculate the expected yields and errors.
Terrific Broth Yield (mg/L) % Total Proteiu
Total Protein 91 mg
Pure GST-Rukh61 15 mg 16.5
Cleaved Rukh61 4 mg 4.4
Table 7: The expression of GST-Rukh61 in Terrific broth.
This shows the percentage of total protein obtained in the form of Rukh61.
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M9 Media Yield (mg/L) % Total Protein
Total Protein 88 mg
Pure GST-Rukh61 14 mg 15.9
Cleaved Rukh61 3.5 mg 4.0
Table 8: The expression of GST-Rukh61 in M9 media.
This shows the percentage of total protein obtained in the form of Rukh61.
Due to difficulties in the resuspension of GST-Rukh61 from pellet form, possibly due 
to the formation of inclusion bodies, attempts have been made to express it at 
different temperatures and shaker speeds, standard LB being used, in the hope that 
this would solve these problems. The results of these experiments are shown in Table 
9 below, and from these results it can be seen that at 30°C and at 37°C, 100 rpm the 
growth was minimal. The use of lower temperatures and/or shaker speeds could help 
with the folding of the protein too.
Temp
CQ
Speed
(rpm)
Total protein 
(mg/L)
Total GST-Rukh61 
(mg/L)
% GST- 
Rukh61
37 200 110 25 22.7
37 100 42 0.8 1.9
30 200 62 1.1 1.8
Table 9: The production o 'GST-Rukh61 une er differing experimental conditions.
All of the experiments were carried out in Luria broth. The experiments not at 37°C and 200 rpm were 
repeated twice in order to check that the results were standard.
Overview
There are certain problems which have arisen in the course of this work which point 
toward the possibility that GST-Rukh61 (and therefore Rukh61 also) was incorrectly, 
or not at all, folded. The first was that it did not bind as well to the glutathione
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Sepharose 4B heads as was expected, there should have been no need to re-apply the 
supernatant to the beads to recover further protein. The second indication was that 
Rukh61 and GST-Rukh61 was very difficult to concentrate, once the concentration 
reached 1 mg/ml the remaining protein precipitated. In addition to this, protein was 
lost on concentration and dialysis through sticking to the membranes and to the sides 
of the container. This would not occur in a folded structure because in a coiled-coil 
the hydrophobic groups are in the centre of the molecule.
A third pointer was that NMR on a sample of GST-Rukh61 failed to show any sign of 
folding that would normally be seen even with a weak sample. See Appendix 2 for the 
spectra.
A sample containing folded protein would have many more peaks between 1-2 ppm 
than are seen in this sample. The peaks that are seen at 1-2 ppm in a folded sample 
arise from through space interactions rather than through bond interactions. The peaks 
observed in this NMR spectrum show the groups present in the proteins, CH2 , OH, 
NH2 etc. but in a 2/3D NMR spectrum this particular sample would not give 
information on GST-Rukh61 conformation.
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4.2 Expression And Purification Of Mb
The Mb was originally received in the E. coli strain X90 but the level of expression of 
the target protein was low in comparison to the overall expression. Prior to 
transformation into another strain, DNA had to be prepared. A single colony is grown 
to saturation in 5 ml of media then diluted 1:100 and again grown to saturation. The 
DNA is then isolated using the QIAGEN protocol for plasmid purification as shown in 
Section 2.
Expression of GST-Mb
From the gel in Figure 14 we know that GST-Mb has been produced. When STE and 
lysozyme is used as the resuspension buffer the pellet is easier to resuspend and does 
not form clumps as it does when PBS is used. Purification on glutathione Sepharose 
4B beads has yielded 5 mg/L of protein, but it appears that a 30 kDa protein is the 
major product.
Figure 14: Gel of the expression of GST- 
Mb.
Lane 1 contains low molecular weight (LMW)
  markers, 31 kDa, 20.4 kDa, 19.7 kDa, 16.9 kDa,
14.4 kDa, 6.1 kDa, and 3.5 kDa (from the top to 
X» 4kDa ■ bottom). Lanes 2-14 show the growth of GST-Mb
l6 9 k^ “ Él after induction with IPTG, with sampling at 30
i44kDa— S  minute intervals.§:.Uair-“
Figure 14 shows the expression of GST-Mb. Lane 1 contains LMW markers, at the 
weights shown in the diagram. Lanes 2-14 show the growth of GST-Mb after 
induction with IPTG, with sampling at 30 minute intervals. As seen in the figure, the
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30 kDa protein mentioned above can be seen two hours after induction. At this point 
the GST-Mb, shown as a band at 35 kDa, began to deteriorate and the unknown band 
at 30 kDa began to be produced. This led to lower yields of GST-Mb than expected 
with a high yield vector. In an attempt to overcome this problem of deterioration, the 
method of production of GST-Mb was altered so that the cells grow until ODeoo^l, 
induction with IPTG is carried out, and the cells are then harvested after 2 hours. The 
concentration of IPTG used to induce growth was altered, fi'om 1 mM to 2 mM. This 
led to a higher yield of GST but not of GST-Mb which appeared to still be 
deteriorating. This is shown by the data in Table 10 and Table 11. These tables show 
how the GST-Mb appears to deteriorate, so that whilst with 2 mM IPTG there is a 
larger amount of total protein produced, less of it is GST-Mb.
Luria Broth 
1 mM IPTG
Yield (mg/L) % Total Protein Error (mg)
Total Protein 118 mg ±20
Pure GST-Mb 7 mg 5.9 ± 3
Cleaved Mb 1.5 mg 1.3 ±0.5
Table 10: The expression of GST-Mb in Luria broth with 1 mlV IPTG.
This shows the percentage of total protein obtained in the form of Mb. The growth was repeated four 
times to give an estimate of the error.
Luria Broth 
2 mM IPTG
Yield (mg/L) % Total Protein Error (mg)
Total Protein 152 mg ±26
Pure GST-Mb 5 mg 3.3 ± 2
Cleaved Mb 1 mg 0.7 ±0.5
Table 11 : The expression of GST-Mb in Luria broth with 2 mlV IPTG.
This shows the percentage of total protein obtained in the form of Mb. The growth was repeated twice 
times to give an estimate of the error.
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M9 Media Yield (mgfL) % Total Protein
Total Protein 50 mg
Pure GST-Mb 1.7 mg 3.4
Table 12: The expression of GST-Mb in M9 media.
This shows the percentage of total protein obtained in the form of GST-Mb. This growth was not 
repeated, nor was the GST-Mb cleaved as it was believed that further work on the optimisation of the 
procedure was required first.
Table 12 shows the one experiment carried out with M9 media and GST-Mb. The 
amount of GST-Mb produced led to the decision to work fiirther on optimisation of 
the protocol before ftirther minimal media experimentation.
Elution and cleavage of GST-Mb
The elution buffer used to remove the GST-fused protein from the glutathione beads 
contains reduced glutathione. This had to be removed from the protein solution prior 
to thrombin cleavage as it interferes with the reaction. The removal can be carried out 
through dialysis against PBS, but as the glutathione was removed, the protein was 
found to fall out of solution. This could be caused by the protein not being properly 
folded, that is, at a concentration of only 1 mg/ml, GST-Mb became insoluble. The 
addition of a reducing agent, Na2S2 0 4 , improved the solubility to 1.5 mg/ml, as did 
reducing the salt content and altering the pH to 6.5. GST-fused Mb could then be 
concentrated using centrifugation or dialysis.
Thrombin cleavage was carried out using 2 units of thrombin per mg of GST-Mb, 
where a unit is defined as the amount of thrombin pro tease required to cleave > 90% of 
100 pg of a test GST-fusion protein in PBS at 22°C in 16 hours. Thrombin cleavage 
yielded 1 mg of cleaved protein from 5 mg of uncleaved protein.
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The cleaved protein solution was applied to the glutathione beads to remove the GST 
from the solution. The GST binds to the beads, the Mb does not.
Concentration of the protein
The concentration of Mb can be carried out using the common method of ultrafiltration 
in an Amicon concentrator where pressure and a stirring bar are used to force the 
solvent through a membrane. This technique has led to a high percentage loss when the 
original amount of protein is low. Centrifirgation through a semi-permeable membrane 
can also be used, but has not been attempted to date. When the concentration of Mb 
reached 1 mg/ml the protein began to precipitate. This problem is still under 
consideration, however Mb appears to be more soluble in a buffer containing less salt 
than there is in PBS and containing a reducing agent such as Na2S2 0 4 .
Overview
GST-Mb has been expressed in the crude extract but there is a lot more to be done 
before structural studies can begin.
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5. Conclusion and Further Work
The aim of this research was to produce and purify the proteins Mb and Rukh61, and 
to determine their 3D structure by NMR. Rukh61 has been expressed but the 
quantities of pure protein that were being produced were small. Further investigations 
into the conditions of production may lead to a higher yield. A variety of problems 
arose in the course of the purification of Rukh61. The proteolytic cleavage and non­
specific binding both led to errors in yield calculations and problems with purity but it 
is thought that both of these problems are now solved. The concentration of Rukh61 is 
still under investigation, as is the solubility in a variety of buffers. Once a suitable 
quantity of Rukh61 has been produced it can be dissolved in a buffer suitable for 
NMR, that is, a buffer which does not interfere with the NMR spectrum such as a 
phosphate buffer.
Mb has only been produced in very small quantities as yet. Work on Mb was put off 
until NMR collection on Rukh61 had been started. This unfortunately has not been 
achieved. Further work on Mb would have begun with the optimisation of the 
expression and purification of the GST-Mb and of the cleavage of the GST tag fi'om 
the target protein.
The first NMR techniques which would have been used are COSY, NOESY and 
TOCSY. The COSY spectra will show the ^H-^H through bond coupling. The 
NOESY spectra will show the through-space distances between the protons, and the 
TOCSY will show the connectivities within each amino acid. Later, more complex 
experiments would have been undertaken and those spectra would have been analysed 
using data firom the earlier experiments.
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6. Appendix
6.1 Structure Prediction For Mb
6.2 NMR Spectra of GST-Rukh61
6.3 NMR Spectroscopy
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Appendix 2
6.2 NMR Spectra of GST-Rukh61
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Appendix 3
6.3 NMR Spectroscopy
Nuclear magnetic resonance was first observed in 1946, and it is the only structural 
technique which can encompass three states of matter. It is the study of the properties 
of a molecule containing magnetic nuclei. It is a radio frequency technique which 
looks at the interaction of radio-frequency pulses with nuclei and the transfer of 
magnetisation between these nuclei.
Identifying the 3D structure of a protein is useful in understanding how that protein 
functions. The first step in the structure determination of proteins by NMR is the 
assignment of the ^^ N chemical shifts, followed by the assignment of nuclear
Overhauser effect (NOE) interactions. The and ^^ N data is obtained from 
isotopically enriched proteins. The principle source of the geometric information that 
is used to solve 3D structures of proteins by NMR comes from the short (< 5 Â) 
interproton distance restraints derived from the NOE measurements. Backbone 
experiments^^ are used to assign the backbone atoms, that is H“, C“, CO, N, and NH. 
Side chain experiments are used to assign the resonances of the side chain atoms.
NMR is a usefiil analytical technique because it uses an environment close to 
biological conditions, it gives information on dynamics and can identify side-chain 
motion. NMR requires solutions concentrated to > 10 mg/ml. NMR is currently 
limited to proteins of < 300 (~30 kDa) amino acids due to the number of resonances 
in larger proteins giving an overcrowded, overlapped spectrum which is very difficult 
to assign, as well as transverse relaxation effects. The reliability of models derived
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from NMR data is measured by the number of constraints per residue that can be 
derived from the experimental data. The accuracy of the NMR structure depends on 
the choice of method for structure calculation, restraining the molecular dynamics 
gives a greater accuracy than using purely distance geometry from the data.^^
The basic concept of 2D NMR spectroscopy is to record the NMR signal as a function 
of time m two dimensions, the key step in 2D NMR being the transfer of 
magnetisation between different nuclei. There are two principle categories of 2D- 
NMR experiments, one is correlated spectroscopy where the cross peaks occur only 
between nuclei that are covalent neighbours, that is, no more than three chemical 
bonds apart. The other type of experiment involves NOE spectroscopy where the 
intensity of the cross peaks illustrates the through-space separation of the nuclei.
NMR experiments fall into two categories, homonuclear correlation experiments and 
heteronuclear correlation experiments. The fundamental NMR experiments are COSY 
(homonuclear), NOESY (homonuclear), HSQC (heteronuclear) and TOCSY 
(homonuclear).
COSY is a 2D technique which gives rise to diagonal and cross peaks. The cross 
peaks come from the transfer of magnetisation between spins. The peaks have a 
multiplet structure from the coupling.
TOCSY is a 2D technique which gives rise to diagonal and cross peaks. Some of the 
cross peaks are relay peaks arising due to the magnetisation on the protons moving to 
protons further away than one bond. This occurs during the spin lock sequence and
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allows the connectivities of a length of C-H or N-H bonds to be traced. The TOCSY 
relies on the cross-polarisation caused by a spin-locking field. For a simple two-spin 
system complete exchange of magnetisation occurs for spin-lock mixing times of 16 J, 
where J is the coupling constant. For biological macromolecules involving large spin 
systems spectra are obtained with a variety of spin locking times.
NOESY is a 2D technique which shows cross peaks between protons that are less than 
5 Â apart in space. The cross peaks are caused by the Nuclear Overhauser 
Enhancement which is the interaction of nuclei through space.
Polarisation transfer can be used to enhance another nucleus. The basic pulse 
sequence for heteronuclear correlation spectroscopy is the ‘Insensitive Nuclei 
Enhanced by Polarisation Transfer’ or INEPT. The INEPT sequence is found in many 
more complex experiments where it is used to transfer magnetisation from one 
nucleus to another heteronucleus.
HMQC was introduced on the principle that optimum sensitivity would be obtained 
by starting with proton polarisation and ending with proton detection, with indirect 
detection of the heteronucleus. The experiment correlates and resonances.
HSQC is the conventional 2D experiment for or correlation. It does not
give any diagonal peaks as all of the magnetisation is transferred. The sequence 
includes two INEPT-type transfers to transfer magnetisation from protons to 
heteronuclei and the reverse which reconverts the magnetisation into
observable magnetisation. This gives a greater enhancement in sensitivity than
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arises from Nuclear Overhauser effects in heteronuclear correlation experiments. The 
spectra obtained have a pure absorptive lineshape with a linewidth narrower than with 
an HMQC due to it not being affected by homonuclear J coupling. The HSQC 
experiment is more sensitive than the HMQC. HMBC (heteronuclear multiple bond 
correlation) is a sensitive technique based on HSQC and HMQC for the determination 
of long range (2/3 bond) heteronuclear connectivities, for example, in proteins NH 
with CaH of the next residue.
For ^^ N NMR studies of proteins, single-quantum coherence experiments give better 
resolution than multiple-quantum^^, due to the dipolar broadening of ^H-^H being 
stronger than the heteronuclear broadening of ^^ N. The obtainable resolution for ^H- 
^^ N shift is dependent on the pulse scheme used.
In NMR of proteins, the signal-to-noise ratio can be increased through the use of 
fractionally deuterated samples."^  ^ This is especially useful if the deuteration is 
combined with uniform ^^ C, ^^ N labelling. These samples can be prepared according 
to papers published by L. E. Kay and co-workers.'^^’^  ^The gain in the signal-to-noise 
ratio results from the increased relaxation times of the H^, N, C« spins due to the 
fractional deuteration. Field gradients and selective radio frequency pulses are used to 
maintain precise control of the water magnetisation in some experiments. This 
technique can be used with ROESY'^^, NOESY and TOCSY for the highfield NMR of 
biomolecules.
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Triple Resonance Experiments For Backbone and Sidecbain Assignments
The experiments HNCA, HN(CO)CA, HCACO, H(CA)NNH, and TOCSY-HMQC 
can be used for backbone assignments. The experiments HCCH-COSY and HCCH- 
TOCSY can be used for side chain assignments. Triple resonance experiments are 
useful for the backbone assignment of doubly labelled proteins, the side chain 
assignments of double labelled proteins, and for the more difficult side chain 
assignments such as Hg, lysine, aromatics, histidine and tiyptophan.
HNCA : In this experiment two cross peaks are seen for each amino acid in the 
protein.' '^  ^ The co-ordinates of the peaks are (Qni, Hci-i, and (Qni, Oci,
This correlates the Hn and in one residue with the of the same and the 
previous residue. The mixing uses J^nh, J^cn, and J^cn-
HN(CO)CA : In this experiment one cross peak is seen for each amino acid in the 
protein.' '^  ^The co-ordinates of the peaks are (% :, Oci-i, This correlates the Hn
and of one residue with the of the previous residue. The mixing uses J^nh> 
J^œN» and J^coca-
H(CA)NNH : The H« (C«)-^^-NH experiment can be used to correlate the NH, ^^ N, 
C“H resonances.' '^* This experiment can be used to show intra-residue connectivity 
between C“H(i), *^N(i), and NH(i) arising from transfer of magnetisation via one bond 
*^Ca-*^N coupling. It can also show sequential inter-residue connectivity between 
C“H(i.i), ^^ N(i), andNH(i) via two-bond coupling.
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TOCSY-HMQC : Spin systems are assigned by correlating NH resonances and the 
*^ N resonances of each residue with *^ C« and C“H resonances of a sample dissolved 
in 90%H20/10%D20. The NH, *^ N, C“H resonances are correlated using the double­
resonance 3D *H-*^N TOCSY-HMQC experiment.
HCACO : This experiment links the carbonyl resonances with the intraresidue C“ and 
H“ resonances.*'*
HCCH-COSY and HCCH-TOCSY
The side chain spin systems are identified by correlating aliphatic *H resonances with 
their attached *^ C resonances using HCCH-COSY and HCCH-TOCSY experiments 
on samples dissolved in D2O. The cross peaks in the spectra obtained using these 
experiments are not symmetric about the diagonal.
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